Login/Sign Up
EPORISE 2000I.U INJECTION belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in persons with chronic kidney disease (CKD), patients affected with HIV, and those receiving chemotherapy for cancer (except for bone marrow or blood cells' cancer). Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia.
EPORISE 2000I.U INJECTION contains a human-made protein known as 'Epoetin alfa' which works by providing signals to the bone marrow to make more red blood cells (RBCs). EPORISE 2000I.U INJECTION helps to reverse anaemia and reduce the need for blood transfusion. EPORISE 2000I.U INJECTION is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, EPORISE 2000I.U INJECTION stimulates the production of this protein in the bone marrow.
EPORISE 2000I.U INJECTION will be administered by a healthcare professional; do not self-administer. The most common side effects of EPORISE 2000I.U INJECTION are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these side effects of EPORISE 2000I.U INJECTION do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
If you have uncontrolled/untreated high blood pressure or red cell aplasia (a type of anaemia) due to epoetin alfa or darbepoetin alfa, please inform your doctor before taking EPORISE 2000I.U INJECTION to avoid any complications. Inform your doctor immediately, if you feel weak, lightheaded, tired, or short of breath, or if your skin looks pale as it may be a sign that the body has stopped responding to EPORISE 2000I.U INJECTION. It is not known whether EPORISE 2000I.U INJECTION will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant and breastfeeding before starting treatment with this medicine. EPORISE 2000I.U INJECTION is a cold chain medicine, and so it has to be stored in the refrigerator between 2-8 degrees Celsius else its efficiency might be lost. Do not store in the freezer or the fridge.
EPORISE 2000I.U INJECTION is a human-made form of naturally occurring erythropoiesis-stimulating protein or erythropoietin (a hormone produced by the kidney's specialized cells and is responsible for protecting red blood cells against destruction and also stimulates the cells of bone marrow to produce more amount of red blood cells). Deficiency of erythropoietin happens when a person is suffering from chronic kidney diseases, which in turn causes low red blood cells count causing anemia. This medicine is primarily indicated for treating anemia (low red blood cell count) in persons with long-term serious (chronic) kidney disease, persons receiving chemotherapy for some types of cancer except for bone marrow or blood cells cancer, and persons taking zidovudine to treat HIV(human immunodeficiency virus). EPORISE 2000I.U INJECTION is also used to reduce the need for red blood cell transfusions in adults having certain types of surgery. EPORISE 2000I.U INJECTION contains a protein 'Epoetin alfa' which works by providing signals to the bone marrow to make more red blood cells.
EPORISE 2000I.U INJECTION can enhance the risk of blood clots and serious heart problems including heart attack so tell your doctor immediately if you notice shortness of breath, sudden numbness or weakness, chest pain, or trouble speaking or understanding. This medicine may speed up tumor growth, or shorten remission or survival time in some people with certain types of cancer. Inform your doctor before taking EPORISE 2000I.U INJECTION if you have heart disease, high blood pressure, kidney disease, stroke, heart attack, blood clot, seizure, or latex allergy. Do not take EPORISE 2000I.U INJECTION if you are pregnant or breastfeeding unless prescribed by the doctor. EPORISE 2000I.U INJECTION should not be given to children below 1 month of age, as safety and effectiveness have not been established. Do not use EPORISE 2000I.U INJECTION from a multi-dose vial when giving medicine to a baby. The multi-dose vial contains an ingredient (benzyl alcohol) that can cause serious side effects or death in very young infants or premature babies. EPORISE 2000I.U INJECTION may affect a person's ability to drive as it may cause convulsions during the initial days of treatment, so a person taking EPORISE 2000I.U INJECTION should avoid driving or operating any machine. Avoid consuming alcohol along with EPORISE 2000I.U INJECTION as it could lead to increased dizziness and sleepiness.
Drug-Drug Interactions: EPORISE 2000I.U INJECTION may have interaction with other chemotherapy drugs (thalidomide, carfilzomib, lenalidomide, pomalidomide), immunosuppressant medication (cyclosporine), antihypertensive medicines (captopril, benazepril, enalapril, lisinopril, moexipril).
Drug-Food Interactions: Avoid alcohol consumption while taking EPORISE 2000I.U INJECTION as it might cause increased dizziness and sleepiness.
Drug-Disease Interactions: EPORISE 2000I.U INJECTION may have interactions with disease conditions such as seizures, hemodialysis, hypertension, porphyria (liver disorders) and thrombotic events.
Anaemia: It occurs when the body has a lower amount of red blood cells or haemoglobin than normal haemoglobin (iron-rich protein responsible for allowing red blood cells to carry more oxygen from the lungs to the rest of the body). In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. Symptoms of anaemia in chronic kidney disease include fatigue or tiredness, shortness of breath, ashen skin, weakness, body aches, chest pain, dizziness, fainting, fast or irregular heartbeat, headache, sleep problems, and trouble concentrating.
About EPORISE 2000I.U INJECTION
EPORISE 2000I.U INJECTION belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in persons with chronic kidney disease (CKD), patients affected with HIV, and those receiving chemotherapy for cancer (except for bone marrow or blood cells' cancer). Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia.
EPORISE 2000I.U INJECTION contains a human-made protein known as 'Epoetin alfa' which works by providing signals to the bone marrow to make more red blood cells (RBCs). EPORISE 2000I.U INJECTION helps to reverse anaemia and reduce the need for blood transfusion. EPORISE 2000I.U INJECTION is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, EPORISE 2000I.U INJECTION stimulates the production of this protein in the bone marrow.
EPORISE 2000I.U INJECTION will be administered by a healthcare professional; do not self-administer. The most common side effects of EPORISE 2000I.U INJECTION are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these side effects of EPORISE 2000I.U INJECTION do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
If you have uncontrolled/untreated high blood pressure or red cell aplasia (a type of anaemia) due to epoetin alfa or darbepoetin alfa, please inform your doctor before taking EPORISE 2000I.U INJECTION to avoid any complications. Inform your doctor immediately, if you feel weak, lightheaded, tired, or short of breath, or if your skin looks pale as it may be a sign that the body has stopped responding to EPORISE 2000I.U INJECTION. It is not known whether EPORISE 2000I.U INJECTION will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant and breastfeeding before starting treatment with this medicine. EPORISE 2000I.U INJECTION is a cold chain medicine, and so it has to be stored in the refrigerator between 2-8 degrees Celsius else its efficiency might be lost. Do not store in the freezer or the fridge.
₹554*
MRP ₹615.5
10% off
₹523.17*
MRP ₹615.5
15% CB
₹92.33 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Product Substitutes
Uses of EPORISE 2000I.U INJECTION
Medicinal Benefits
EPORISE 2000I.U INJECTION is a human-made form of naturally occurring erythropoiesis-stimulating protein or erythropoietin (a hormone produced by the kidney's specialized cells and is responsible for protecting red blood cells against destruction and also stimulates the cells of bone marrow to produce more amount of red blood cells). Deficiency of erythropoietin happens when a person is suffering from chronic kidney diseases, which in turn causes low red blood cells count causing anemia. This medicine is primarily indicated for treating anemia (low red blood cell count) in persons with long-term serious (chronic) kidney disease, persons receiving chemotherapy for some types of cancer except for bone marrow or blood cells cancer, and persons taking zidovudine to treat HIV(human immunodeficiency virus). EPORISE 2000I.U INJECTION is also used to reduce the need for red blood cell transfusions in adults having certain types of surgery. EPORISE 2000I.U INJECTION contains a protein 'Epoetin alfa' which works by providing signals to the bone marrow to make more red blood cells.
Side Effects of EPORISE 2000I.U INJECTION
Directions for Use
Storage
Drug Warnings
EPORISE 2000I.U INJECTION can enhance the risk of blood clots and serious heart problems including heart attack so tell your doctor immediately if you notice shortness of breath, sudden numbness or weakness, chest pain, or trouble speaking or understanding. This medicine may speed up tumor growth, or shorten remission or survival time in some people with certain types of cancer. Inform your doctor before taking EPORISE 2000I.U INJECTION if you have heart disease, high blood pressure, kidney disease, stroke, heart attack, blood clot, seizure, or latex allergy. Do not take EPORISE 2000I.U INJECTION if you are pregnant or breastfeeding unless prescribed by the doctor. EPORISE 2000I.U INJECTION should not be given to children below 1 month of age, as safety and effectiveness have not been established. Do not use EPORISE 2000I.U INJECTION from a multi-dose vial when giving medicine to a baby. The multi-dose vial contains an ingredient (benzyl alcohol) that can cause serious side effects or death in very young infants or premature babies. EPORISE 2000I.U INJECTION may affect a person's ability to drive as it may cause convulsions during the initial days of treatment, so a person taking EPORISE 2000I.U INJECTION should avoid driving or operating any machine. Avoid consuming alcohol along with EPORISE 2000I.U INJECTION as it could lead to increased dizziness and sleepiness.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Anaemia: It occurs when the body has a lower amount of red blood cells or haemoglobin than normal haemoglobin (iron-rich protein responsible for allowing red blood cells to carry more oxygen from the lungs to the rest of the body). In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. Symptoms of anaemia in chronic kidney disease include fatigue or tiredness, shortness of breath, ashen skin, weakness, body aches, chest pain, dizziness, fainting, fast or irregular heartbeat, headache, sleep problems, and trouble concentrating.